PENK

PENK Full Name

proenkephalin

PENK Introduction

Proenkephalin, abbreviated as PENK, is a key member of the opioid neuropeptide precursor family and a core component of the body's endogenous opioid system. Encoded by the PENK gene, it is proteolytically processed into multiple bioactive neuropeptides that regulate a wide range of physiological processes, including pain perception, emotional regulation, and neuroimmune interaction. In recent years, extensive research has revealed its critical pathophysiological roles in various human diseases and great potential as a clinical biomarker and therapeutic target, making it a research hotspot in neuroscience, nephrology, and rheumatology.

Figure1. Signaling Pathway of PENK.

Signaling Pathway
When enkephalins bind to these receptors on neurons:
Inhibition of Calcium Channels: Prevents the influx of calcium, stopping the neuron from releasing excitatory neurotransmitters (like Substance P or Glutamate).
Activation of Potassium Channels: Causes potassium to flow out, hyperpolarizing the cell and making it harder to fire an action potential.

Clinical Significance
Neuropathic Pain
In conditions of chronic pain, the PENK system can become dysregulated. Gene therapy approaches aiming to overexpress PENK in the spinal cord have been investigated as a way to provide long-term, localized pain relief without the side effects of systemic morphine.
Huntington's Disease
Loss of enkephalin-producing neurons in the striatum (a part of the brain controlling movement) is one of the earliest pathological changes in Huntington's disease, contributing to the motor symptoms (chorea).
Biomarker Potential
Recent studies suggest that circulating levels of Proenkephalin fragments (specifically penKid) can serve as a biomarker for kidney function and sepsis prognosis in critical care settings.

Alternate Names for PENK

PENK; proenkephalin; proenkephalin-A; enkephalin A; preproenkephalin;